Nitric oxide synthase and neuronal vulnerability in parkinson's disease
暂无分享,去创建一个
Y. Agid | S. Hunot | B. Faucheux | A. Mouatt-Prigent | E. Hirsch | B. Brugg | Y. Agid | F. Boissière | S. Hunot | F. Boissière | B. Faucheux | B. Brugg | A. Mouatt-Prigent | E. C. Hirsch | F. Boissiere | A. Mouatt‐Prigent
[1] Y Agid,et al. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Hentze,et al. Nitric oxide signaling to iron-regulatory protein: direct control of ferritin mRNA translation and transferrin receptor mRNA stability in transfected fibroblasts. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Mong,et al. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures , 1994, Neuropharmacology.
[4] D. Hanley,et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains , 1994, Annals of neurology.
[5] D. Grzybicki,et al. Modulation of inducible nitric oxide synthase expression in astroglial cells , 1994, Neuropharmacology.
[6] S. Paik,et al. Synergistic cooperation between phorbol ester and IFN-gamma for induction of nitric oxide synthesis in murine peritoneal macrophages. , 1994, Journal of immunology.
[7] J. Bolaños,et al. Nitric Oxide‐Mediated Inhibition of the Mitochondrial Respiratory Chain in Cultured Astrocytes , 1994, Journal of neurochemistry.
[8] E. Hirsch,et al. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease , 1994, Neuroscience Letters.
[9] M. N. Wallace,et al. NADPH-diaphorase activity in activated astrocytes represents inducible nitric oxide synthase , 1994, Neuroscience.
[10] B. Bogerts,et al. The distribution of nitric oxide synthase immunoreactivity in the human brain , 1994, Neuroscience.
[11] James B. Mitchell,et al. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[12] Takahiro Matsumoto,et al. A correlation between soluble brain nitric oxide synthase and NADPH-diaphorase activity is only seen after exposure of the tissue to fixative , 1993, Neuroscience Letters.
[13] K. Maiese,et al. Reactive astrocytes express NADPH diaphorase in vivo after transient ischemia , 1993, Neuroscience Letters.
[14] C. Damais,et al. IL1 and TNFα induce cGMP formation in C6 astrocytoma cells via the nitridergic pathway , 1993, Brain Research.
[15] G. Nisticó,et al. Cytokine-induced nitric oxide generation by cultured astrocytoma cells involves Ca(++)-calmodulin-independent NO-synthase. , 1993, Biochemical and biophysical research communications.
[16] C. W. Olanow,et al. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.
[17] T. Molitor,et al. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.
[18] S H Snyder,et al. A novel neuronal messenger molecule in brain: The free radical, nitric oxide , 1992, Annals of neurology.
[19] M. Simmons,et al. Induction of Nitric Oxide Synthase in Glial Cells , 1992, Journal of neurochemistry.
[20] K. Jellinger,et al. Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.
[21] G. Kreutzberg,et al. Cytotoxicity of microglia , 1992, Journal of Neuroimmunology.
[22] P. Tempst,et al. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[23] Terry D. Lee,et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. , 1992, Science.
[24] J. Cunningham,et al. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. , 1992, The Journal of biological chemistry.
[25] H. Kimura,et al. Histochemical mapping of nitric oxide synthase in the rat brain , 1992, Neuroscience.
[26] S. Snyder,et al. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase , 1991, Neuron.
[27] S. Snyder,et al. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Snyder,et al. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase , 1991, Nature.
[29] Yves Agid,et al. Parkinson's disease: pathophysiology , 1991, The Lancet.
[30] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[31] S. Vincent,et al. Neuronal NADPH diaphorase is a nitric oxide synthase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[32] B. Freeman,et al. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. , 1991, The Journal of biological chemistry.
[33] Y. Agid,et al. Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis , 1991, Journal of neurochemistry.
[34] D. Reif,et al. Nitric oxide mediates iron release from ferritin. , 1990, Archives of biochemistry and biophysics.
[35] N. Delhaye-bouchaud,et al. Interleukin‐1 Hyperproduction by In Vitro Activated Peripheral Macrophages from Cerebellar Mutant Mice , 1990, Journal of neurochemistry.
[36] S. Snyder,et al. Localization of nitric oxide synthase indicating a neural role for nitric oxide , 1990, Nature.
[37] C. Marsden,et al. Decreased Ferritin Levels in Brain in Parkinson's Disease , 1990, Journal of neurochemistry.
[38] C. Marsden,et al. Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.
[39] B. Freeman,et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[40] C. Marsden,et al. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.
[41] C. Nathan,et al. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells , 1989, The Journal of experimental medicine.
[42] Peter Riederer,et al. Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.
[43] C. Marsden,et al. Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.
[44] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[45] A. Graybiel,et al. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.
[46] M. Beal,et al. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: Normal anatomy and alterations in alzheimer's disease , 1988, Annals of neurology.
[47] J. B. Martin,et al. Selective sparing of a class of striatal neurons in Huntington's disease. , 1985, Science.
[48] S. Hsu,et al. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[49] V. Pickel,et al. CYTOCHEMICAL LOCALIZATION OF BRAIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED)-DEPENDENT DEHYDROGENASES QUALITATIVE AND QUANTITATIVE DISTRIBUTIONS , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[50] Y Agid,et al. Are dopaminergic neurons selectively vulnerable to Parkinson's disease? , 1993, Advances in neurology.
[51] P Riederer,et al. The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease. , 1993, Advances in neurology.
[52] E. Hirsch. Does oxidative stress participate in nerve cell death in Parkinson's disease? , 1993, European neurology.
[53] P. Braquet,et al. Nitric oxide synthase induction in glial cells: effect on neuronal survival. , 1993, Life sciences.
[54] C. Théry,et al. Les macrophages cérébraux : rôle dans les remaniements morphologiques et la dégénerescence des neurones , 1991 .
[55] S. Snyder,et al. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[56] K. Earle. Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. , 1968, Journal of neuropathology and experimental neurology.